Shanghai HeartCare Medical Technology Corporation Limited
Shanghai HeartCare Medical Technology Corporation Limited, commonly referred to as HeartCare, is a leading player in the medical technology industry, headquartered in Shanghai, China. Founded in 2005, the company has established itself as a pioneer in cardiovascular health solutions, focusing on innovative diagnostic and therapeutic devices. HeartCare's core offerings include advanced cardiac monitoring systems and minimally invasive surgical tools, designed to enhance patient outcomes and streamline healthcare processes. The company is recognised for its commitment to quality and innovation, positioning itself as a trusted partner in the medical community. With a strong presence in Asia and expanding operations globally, HeartCare has achieved significant milestones, including numerous patents and collaborations with top-tier medical institutions. Its dedication to advancing heart health technology continues to solidify its market position as a frontrunner in the field.
DitchCarbon Score
How does Shanghai HeartCare Medical Technology Corporation Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Shanghai HeartCare Medical Technology Corporation Limited's score of 27 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Shanghai HeartCare Medical Technology Corporation Limited's reported carbon emissions
In 2024, Shanghai HeartCare Medical Technology Corporation Limited reported total carbon emissions of approximately 1,830,000 kg CO2e. This figure includes about 12,400 kg CO2e from Scope 1 emissions and around 1,817,600 kg CO2e from Scope 2 emissions. In comparison, the company's emissions for 2023 were approximately 2,530,000 kg CO2e, with Scope 1 emissions at about 7,400 kg CO2e and Scope 2 emissions at approximately 2,522,600 kg CO2e. This indicates a significant reduction in total emissions of about 700,000 kg CO2e year-on-year. Despite these reductions, Shanghai HeartCare has not set any specific reduction targets or climate pledges, nor does it disclose any Scope 3 emissions data. The company operates independently without cascading emissions data from a parent organisation, indicating a standalone approach to its carbon footprint management. Overall, while Shanghai HeartCare has made strides in reducing its emissions, the absence of formal climate commitments or targets suggests potential areas for improvement in its sustainability strategy.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2023 | 2024 | |
|---|---|---|
| Scope 1 | 7,400 | 00,000 |
| Scope 2 | 2,522,600 | 0,000,000 |
| Scope 3 | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Shanghai HeartCare Medical Technology Corporation Limited is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
